Paradox of irAEs in Patients with Locally Advanced or Metastatic Urothelial Cancer Receiving Atezolizumab Physician's Weekly, 20 Dec 2023 The following is a summary of “Immune-Related Adverse Events Paradox In Locally Advanced Or Metastatic Urothelial Cancer…